摘要
目的探析无痛分娩应用舒芬太尼复合罗哌卡因硬膜外麻醉的临床应用价值。方法由该院自2018年1月—2019年12月接收的产妇中抽取60名产妇,选为观察对象给予分组,对照组(30名)产妇行自然分娩,观察组(30名)产妇在舒芬太尼复合罗哌卡因硬膜外麻醉下行无痛分娩。对产妇产程、产后出血情况予以记录,评估分娩疼痛与新生儿Apgar评分,对比产妇分娩方式的选择情况。结果对照组产妇分娩全产程时间(624.32±38.45)min、产后出血量(235.17±23.75)mL,高于观察组(t=11.510、10.790,P<0.05)。观察组产妇分娩疼痛评分(3.52±1.53)分、新生儿Apgar评分(9.79±0.21)分,优于对照组(t=5.729、6.614,P<0.05)。对照组自然分娩83.3%(25/30)少于观察组的93.4%(28/30)(P<0.05)。结论舒芬太尼复合罗哌卡因硬膜外麻醉在无痛分娩中麻醉效果确切,安全性较高,缩短了产妇的分娩时间,自然分娩率也较高,存在较高的临床应用价值。
Objective To explore the clinical value of sufentanil combined with ropivacaine epidural anesthesia for painless labor.Methods Sixty pregnant women were selected from the pregnant women received in the hospital from January 2018 to December 2019,and were selected as observation subjects to be divided into groups.Fentanyl combined with ropivacaine epidural anesthesia for painless labor.The records of maternal labor and postpartum hemorrhage were recorded,and the labor pain and neonatal Apgar score were evaluated,and the selection of maternal delivery methods was compared.Results The time of delivery in the control group was(624.32±38.45)min and the postpartum hemorrhage(235.17±23.75)mL,which was higher than that in the observation group(t=11.510,10.790,P<0.05).Observation group maternal labor pain score(3.52±1.53)points and neonatal Apgar score(9.79±0.21)points were better than the control group(t=5.729,9.614,P<0.05).The natural delivery rate of the control group was 83.3%(25/30)less than 93.4%(28/30)of the observation group(P<0.05).Conclusion Sufentanil combined with ropivacaine epidural anesthesia is effective in painless labor,with high safety,shortening the delivery time of women,and the natural delivery rate is also high,which has high clinical application value.
作者
彭薇薇
PENG Wei-wei(Department of Anesthesiology,Xuyi County Traditional Chinese Medicine Hospital,Xuyi,Jiangsu Province,211700 China)
出处
《系统医学》
2020年第14期56-58,共3页
Systems Medicine